MMedication Read More XENE Files NDA for Epilepsy Drug, Falls on Depression Studies’ SetbackSeptember 18, 2026 Xenon Pharmaceuticals XENE announced that it has submitted a new drug application (NDA) to the FDA for azetukalner,…